Health

Whether pharma, private or public healthcare, med-or-healthtech, for institutions, corporations or investors we serve, Health’s is central to CMI, not just as a business but through its societal impact at any geographical level.

Due to its ever-more impactful place in society, healthcare has become a business critical sector for our investor clients.

Health is one of the most dynamic sectors that CMI services. It feeds on a rich set of transformations that occur in parallel: the evolution of healthcare systems, the steady stream of disruptive innovations impacting diagnostic and treatment, digital services and AI further accelerating the above, on a backdrop of rapidly evolving needs of aging populations.

  • Improving access to healthcare and innovation
    We integrate these perpetual challenges into our thinking, offering numerous investment and consolidation opportunities in the areas which follow.
  • Transformation of the healthcare system
    Intra- and inter-private practice consolidation, digitalization of practices (through software, services, AI), and the development of outpatient and home care.
  • Innovative dynamics in industry
    Transformation of the pharmaceutical ecosystem, diversification (sector, geographic) of medical device players, while addressing the challenge of sovereignty and supply chain control.
  • Development of healthcare services
    Process outsourcing, high-value consulting (regulatory, clinical, market), and IT integration.

We support our investor clients in the healthcare sector.

Our long-standing expertise in healthcare, including with regulatory authorities and healthcare operators, allows us to best support our investor clients. We provide them with a 360° view of SMEs and mid-cap companies operating in this complex sector.

A detailed understanding of market access procedures and a clear vision of sector development prospects (innovation, reforms) are the foundation of our strategic healthcare due diligence.

We have built our expertise across the following areas of intervention:

  • Consolidation of private healthcare
    Constrained medical resources lead healthcare professionals to consolidate. We support investors in their equity investments in healthcare consolidation platforms.
  • Manufacturing and distribution of medical devices
    We support Private Equity firms as they seek to invest in innovative medical device companies (equipment, single-use devices), whether intended for hospitals, healthcare professionals, or patients.
  • Pharmaceutical industry service providers
    The increasing outsourcing of pharmaceutical industry services is generating investment opportunities in numerous sub-sectors: engineering consulting, clinical research, and regulatory affairs.
  • Healthcare software
    The digitalization of the healthcare system and healthcare manufacturers represents investment opportunities for our clients: telemedicine, patient record management, appointment scheduling optimization, and artificial intelligence.

Sector deep dive : 

Healthcare industry
Over the last 20 years, CMI has been providing expertise to pharmaceutical, medical device, and e-health companies, as well as their partners, to help them meet the challenges they face.

Learn More

Healthcare and social care facilities
We assist healthcare facilities by prioritizing projects, mobilizing stakeholders around a shared ambition, and transforming organizations to best meet healthcare needs of their respective populations.

Learn More

Social protection
We work with stakeholders in various sectors of the social protection system and support projects aimed at improving the daily lives of millions of citizens.

Learn More

CONTACTS
Hugo Perier

Expert Private Equity

Marc Lefrançois

Expert Industries de la Santé

Avis d’experts
New Deal: CMI supports Weetec in its Vendor Due Diligence
Private Equity
Patrimonia 2024: Financial Advisory Services Thriving in France
Bâtiment & Immobilier Private Equity
New Deal: CMI Supports Sodeprint Group, Ouest Croissance, and Bpifrance in Strategic Growth Initiative
Private Equity